# OnCo record beijing-pearl-biotechnology-limited-liability-company (company). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/companies/beijing-pearl-biotechnology-limited-liability-company/>
  a schema:Organization ;
  onco:kind "company" ;
  schema:identifier "beijing-pearl-biotechnology-limited-liability-company" ;
  schema:name "Beijing Pearl Biotechnology Limited Liability Company"@en ;
  schema:description "Beijing Pearl Biotechnology Limited Liability Company is a Chinese developer in Beijing that sponsors 3 registered cancer trials of PLB1001 and Temozolomide."@en ;
  schema:url <https://onco.cc/companies/beijing-pearl-biotechnology-limited-liability-company/> ;
  schema:dateModified "2026-09-11"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/search?spons=Beijing%20Pearl%20Biotechnology%20Limited%20Liability%20Company> ;
  onco:tag "ctgov-sponsor", "china", "registry-only" ;
  schema:addressCountry "CN" ;
  onco:trials <https://onco.cc/trials/nct06105619/>, <https://onco.cc/trials/nct05989542/>, <https://onco.cc/trials/nct06930794/> .